Investment

Sweden’s industrial development fund failed to sell any shares in portfolio companies in 2007–2008 and wrote down the value of its life sciences investments.

As stock markets turn their backs on the high-risk sectors, France Biotech’s annual survey reveals the depths to which investment has fallen.

Who’s going to rescue the lab that’s come up with a smart, commercially viable invention, or a start-up looking for second stage financing?

For the first time small companies will be able to use European Investment Bank (EIB) loans to help mitigate the effects of the current credit crisis.

A new report from Nesta shows that private money now accounts for only 43 per cent of early stage investments in the UK, leaving public funds to prop up innovation.